Results 41 to 50 of about 8,497 (207)

Salvage Boron Neutron Capture Therapy for Malignant Brain Tumor Patients in Compliance with Emergency and Compassionate Use: Evaluation of 34 Cases in Taiwan

Biology, 2021
Although boron neutron capture therapy (BNCT) is a promising treatment option for malignant brain tumors, the optimal BNCT parameters for patients with immediately life-threatening, end-stage brain tumors remain unclear.
Yi-Wei Chen, Yi-Yen Lee, Chun-Fu Lin, Po-Shen Pan, Jen-Kun Chen, Chun-Wei Wang, Shih-Ming Hsu, Yu-Cheng Kuo, Tien-Li Lan, Sanford P. C. Hsu, Muh-Lii Liang, Robert Hsin-Hung Chen, Feng-Chi Chang, Chih-Chun Wu, Shih-Chieh Lin, Hsiang-Kuang Liang, Jia-Cheng Lee, Shih-Kuan Chen, Hong-Ming Liu, Jinn-Jer Peir, Ko-Han Lin, Wen-Sheng Huang, Kuan-Hsuan Chen, Yu-Mei Kang, Shueh-Chun Liou, Chun-Chieh Wang, Ping-Ching Pai, Chih-Wei Li, Daniel Quah Song Chiek, Tai-Tong Wong, Shih-Hwa Chiou, Yee Chao, Hiroki Tanaka, Fong-In Chou, Koji Ono   +34 more
doaj   +1 more source

An Introduction to Boron Neutron Therapy (BNCT): Current Status and Future Outlook

Iranian South Medical Journal, 2021
Boron neutron capture therapy (BNCT) is based on the nuclear reaction, such that B-10 irradiated with low-energy thermal neutrons produces alpha particles with high linear energy transfer and lithium-7. Clinically, BNCT is used primarily for treatment of
Malehe Omrani, Esmaeil Jafari, Zenab Alipour, Hajar Zarei   +3 more
doaj  

Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors

Вестник рентгенологии и радиологии, 2016
Boron neutron capture therapy (BNCT) that is of the highest attractiveness due to its selective action directly on malignant tumor cells is a promising approach to treating cancers.
V. V. Kanygin, A. I. Kichigin, N. V. Gubanova, S. Yu Taskaev   +3 more
doaj   +1 more source

Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy

Biology, 2022
Boron neutron capture therapy (BNCT) is a non-invasive therapeutic technique for treating malignant tumors, however, methods to evaluate its therapeutic efficacy and adverse reactions are lacking.
Shoji Imamichi, Lichao Chen, Tasuku Ito, Ying Tong, Takae Onodera, Yuka Sasaki, Satoshi Nakamura, PierLuigi Mauri, Yu Sanada, Hiroshi Igaki, Yasufumi Murakami, Minoru Suzuki, Jun Itami, Shinichiro Masunaga, Mitsuko Masutani   +14 more
doaj   +1 more source

A Dual-Beam Irradiation Facility for a Novel Hybrid Cancer Therapy

, 2012
In this paper we present the main ideas and discuss both the feasibility and the conceptual design of a novel hybrid technique and equipment for an experimental cancer therapy based on the simultaneous and/or sequential application of two beams, namely a
A Doria, A Rosen, AG Pakhomov, AR Orlando, B Born, BS Jang, C Furse, C Yu, D Satoh, DT Pooley, E Bründermann, E Giovenale, EA Nanni, G Andocs, GJ Hyland, GJ Wilmink, GJ Wilmink, H Frohlich, H Kamada, H Kamada, J Wang, JR Reimers, K Mileva, MR Scarfì, Norio Miyoshi, P Wusta, PH Siegel, R Barth, RF Barth, S Banik, S Sabchevski, S Sabchevski, Shintaro Ishiyama, Svilen Petrov Sabchevski, T Idehara, T Idehara, T Idehara, T Sato, T Tatsukawa, T Tatsukawa, T Tatsukawa, T Tatsukawa, TA Buchholz, Toshiaki Tatsukawa, Toshitaka Idehara, Y Nakagawa   +45 more
core   +1 more source

Physics for BNCT

Journal of Physics: Conference Series, 2006
The experience from physical field for the BNCT project realized in NRI (Czech Republic) is presented. The physical methods and equipments for the design, construction and operation of facility for medical application are summarized. The comment is concentrated to the following items, especially: Sources for BNCT, calculation methods, measurement ...
J Burian, S Flibor, M Marek, J Rejchrt, L Viererbl, I Tomandl   +5 more
openaire   +1 more source

Chitosan-lactobionic acid-thioctic acid-modified hollow mesoporous silica composite loaded with carborane for boron neutron capture therapy of hepatocellular carcinoma

Materials & Design, 2022
Nanocarriers have been recognized as an effective strategy for developing novel boron-containing delivery agents for boron neutron capture therapy (BNCT) of refractory tumors.
Taofeng Zhang, Dan Xu, Yangman Yi, Yu Wang, Zhencun Cui, Xiujuan Chen, Qianlong Ma, Fuxiang Song, Bowu Zhu, Zhongfang Zhao, Judong Cao, Dian He, Ximeng Chen, Bin Liu   +13 more
doaj   +1 more source

Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro [PDF]

, 2013
BACKGROUND: Glioma stem cells in the quiescent state are resistant to clinical radiation therapy. An almost inevitable glioma recurrence is due to the persistence of these cells.
Bin Li, Guilin Chen, Jie Wu, Ting Sun, Xueshun Xie, Yongxin Wei, Youxin Zhou, Ziwei Du, Zizhu Zhang   +8 more
core   +1 more source

BNCT-RTPE: BNCT radiation treatment planning environment

, 1995
Several improvements have been developed for the BNCT radiation treatment planning environment (BNCT-Rtpe) during 1994. These improvements have been incorporated into Version 1.0 of BNCT-Rtpe which is currently installed at the INEL, BNL, Japanese Research Center (JRC), and Finland`s Technical Research Center.
D E Wessol, F J Wheeler, R S Babcock
openaire   +2 more sources

Monte-Carlo simulation of neutron transmission through nanocomposite materials for neutron-optics applications

, 2018
Nanocomposites enable us to tune parameters that are crucial for use of such materials for neutron-optics applications such as diffraction gratings by careful choice of properties such as species (isotope) and concentration of contained nanoparticles ...
Blaickner, M., Demirel, B., Drevenšek-Olenik, I., Fally, M., Flauger, P., Geltenbort, P., Hasegawa, Y., Klepp, J., Kurinjimala, R., Ličen, M., Pruner, C., Sponar, S., Tomita, Y.   +12 more
core   +4 more sources